{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/MCRB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T05:37:56.994Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6665,"canonical_name":"Seres Therapeutics, Inc.","cik":"0001609809","uei":null,"lei":null,"duns":null,"ticker":"MCRB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":21},"count":21,"timeline":[{"ts":"2026-07-09","kind":"sec.filing","form_type":"S-8","title":"S-8 — Seres Therapeutics, Inc. — 2026-07-09","url_slug":"/sec/cik-0001609809/s-8/0001193125-26-299675","accession_number":"0001193125-26-299675","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Seres Therapeutics, Inc. — 2026-07-08","url_slug":"/sec/cik-0001609809/8-k/0001193125-26-298525","accession_number":"0001193125-26-298525","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Seres Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001609809/4/0001193125-26-295064","accession_number":"0001193125-26-295064","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Seres Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001609809/4/0001193125-26-295071","accession_number":"0001193125-26-295071","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Seres Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001609809/8-k/0001193125-26-258366","accession_number":"0001193125-26-258366","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Seres Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001609809/8-k/0001193125-26-251548","accession_number":"0001193125-26-251548","importance":35},{"ts":"2026-05-19","kind":"sec.form144","reporter":"TERESA L YOUNG","title":"Officer","shares":167,"usd_value":1284,"security_title":"Common","approx_sale_date":"2026-05-19","accession_number":"0001950047-26-004748","importance":40.000256846},{"ts":"2026-05-19","kind":"sec.filing","form_type":"144","title":"144 — Seres Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001609809/144/0001950047-26-004748","accession_number":"0001950047-26-004748","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Seres Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001609809/4/0001193125-26-230727","accession_number":"0001193125-26-230727","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Seres Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001609809/4/0001193125-26-230732","accession_number":"0001193125-26-230732","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Seres Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001609809/4/0001193125-26-230733","accession_number":"0001193125-26-230733","importance":30},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Shaff Eric D.","title":null,"shares":259,"price_per_share":7.53,"usd_value":1950,"security_title":"Common Stock","importance":35.00195027},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"DesRosier Thomas","title":"See Remarks","shares":79,"price_per_share":7.53,"usd_value":595,"security_title":"Common Stock","importance":35.00059487},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Henn Matthew R","title":"See Remarks","shares":77,"price_per_share":7.53,"usd_value":580,"security_title":"Common Stock","importance":35.00057981},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Brady Kelly","title":"See Remarks","shares":59,"price_per_share":7.53,"usd_value":444,"security_title":"Common Stock","importance":35.00044427},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"DesRosier Thomas","title":"See Remarks","shares":244,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Brady Kelly","title":"See Remarks","shares":180,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Henn Matthew R","title":"See Remarks","shares":238,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Shaff Eric D.","title":null,"shares":722,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Seres Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001609809/def-14a/0001193125-26-182036","accession_number":"0001193125-26-182036","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Seres Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001609809/defa14a/0001140361-26-017092","accession_number":"0001140361-26-017092","importance":30}]}